Comparative Effectiveness for AI MedTech
Published on: 04/09/2024
Why comparing your AI MedTech solution to the status quo isn’t enough for payer approval.
AIAI MedTechMedicareReal-World EvidenceRWEClinical UtilityPayer ExpectationsComparative EffectivenessPolicy
AI MedTech Reimbursement: Insights from Recent Literature
Published on: 13/08/2024
A review of what peer-reviewed publications reveal about payer adoption of AI tools.
AIAI MedTechMedicarePayer CoverageEvidenceCodingArtificial intelligenceHealth Technology AssessmentHTANovelValue-basedPayer Engagement
The Myth of ‘Build First, Worry Later’: Why Early Reimbursement Strategy is the Key to MedTech Survival
Published on: 03/08/2024
Why U.S. reimbursement strategy should begin long before FDA approval if you want to survive.
AIAI/MLReimbursement StrategyPayerPayer EngagementProduct DevelopmentHealthcare StakeholdersClinical UtilityEvidence
Relearning English When it Comes to FDA and CMS Jargon
Published on: 04/06/2024
MedTech teams often misunderstand what regulators mean. This article translates FDA and CMS jargon into actionable insights for reimbursement.
FDACMSFood and Drug AdministrationMedicareMedicaidAIExperimentalInvestigational
